trisequens has been researched along with nandrolone in 2 studies
Studies (trisequens) | Trials (trisequens) | Recent Studies (post-2010) (trisequens) | Studies (nandrolone) | Trials (nandrolone) | Recent Studies (post-2010) (nandrolone) |
---|---|---|---|---|---|
56 | 35 | 1 | 2,995 | 314 | 531 |
Protein | Taxonomy | trisequens (IC50) | nandrolone (IC50) |
---|---|---|---|
Androgen receptor | Rattus norvegicus (Norway rat) | 0.0031 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gräser, T; Koytchev, R; Müller, A; Oettel, M | 1 |
Carlström, K; Conner, P; Gräser, T; Skoog, L; Söderqvist, G; Tani, E; von Schoultz, B; Walter, F | 1 |
2 trial(s) available for trisequens and nandrolone
Article | Year |
---|---|
Comparison of the efficacy and endometrial safety of two estradiol valerate/dienogest combinations and Kliogest for continuous combined hormone replacement therapy in postmenopausal women.
Topics: Biopsy; Breast Diseases; Double-Blind Method; Drug Combinations; Endometrial Hyperplasia; Endometrium; Estradiol; Estriol; Estrogen Replacement Therapy; Female; Humans; Nandrolone; Norethindrone; Postmenopause; Prospective Studies; Therapeutic Equivalency; Treatment Outcome; Uterine Hemorrhage | 2000 |
Breast cell proliferation in postmenopausal women during HRT evaluated through fine needle aspiration cytology.
Topics: Biopsy, Needle; Breast; Cell Division; Double-Blind Method; Drug Combinations; Estradiol; Estriol; Estrogen Replacement Therapy; Estrone; Female; Humans; Ki-67 Antigen; Middle Aged; Nandrolone; Norethindrone; Postmenopause; Prospective Studies | 2003 |